In human AML, elevated expression of Trib2 was shown to be driven by the transcription factors E2F1 [9] and NOTCH1 [10] where the latter was found to be aberrantly activated in an AML subset that has a mixed myeloid/T-lymphoid phenotype [10]. Here, TRIB2 is linked to acute myeloid leukemia.